These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 9816281)
1. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Younes M; Lechago LV; Lechago J Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281 [TBL] [Abstract][Full Text] [Related]
2. Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia. Younes M; Ertan A; Lechago LV; Somoano J; Lechago J Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):303-5. PubMed ID: 9149888 [TBL] [Abstract][Full Text] [Related]
3. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Younes M; Juarez D; Lechago LV; Lerner SP Anticancer Res; 2001; 21(1B):575-8. PubMed ID: 11299807 [TBL] [Abstract][Full Text] [Related]
4. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J Cancer Res; 1996 Mar; 56(5):1164-7. PubMed ID: 8640778 [TBL] [Abstract][Full Text] [Related]
5. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas. Younes M; Pathak M; Finnie D; Sifers RN; Liu Y; Schwartz MR Anticancer Res; 2000; 20(5C):3775-9. PubMed ID: 11268453 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma. Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F Oncology; 2001; 60(2):162-9. PubMed ID: 11244332 [TBL] [Abstract][Full Text] [Related]
7. GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer. Rudlowski C; Becker AJ; Schroder W; Rath W; Büttner R; Moser M Am J Clin Pathol; 2003 Nov; 120(5):691-8. PubMed ID: 14608894 [TBL] [Abstract][Full Text] [Related]
8. [Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma]. Zhou YL; Deng CS Ai Zheng; 2005 Jun; 24(6):685-9. PubMed ID: 15946479 [TBL] [Abstract][Full Text] [Related]
9. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Younes M; Brown RW; Mody DR; Fernandez L; Laucirica R Anticancer Res; 1995; 15(6B):2895-8. PubMed ID: 8669885 [TBL] [Abstract][Full Text] [Related]
10. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975 [TBL] [Abstract][Full Text] [Related]
11. Fatty acid binding protein 6 is overexpressed in colorectal cancer. Ohmachi T; Inoue H; Mimori K; Tanaka F; Sasaki A; Kanda T; Fujii H; Yanaga K; Mori M Clin Cancer Res; 2006 Sep; 12(17):5090-5. PubMed ID: 16951225 [TBL] [Abstract][Full Text] [Related]
12. Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation. Hauptmann S; Grünewald V; Molls D; Schmitt WD; Köbel M; Kriese K; Schürmann A Anticancer Res; 2005; 25(5):3431-6. PubMed ID: 16101160 [TBL] [Abstract][Full Text] [Related]
13. Expression of facilitative glucose transporters in gastric tumors. Noguchi Y; Marat D; Saito A; Yoshikawa T; Doi C; Fukuzawa K; Tsuburaya A; Satoh S; Ito T Hepatogastroenterology; 1999; 46(28):2683-9. PubMed ID: 10522065 [TBL] [Abstract][Full Text] [Related]
14. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas. Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919 [TBL] [Abstract][Full Text] [Related]
15. Significance of GLUT1 expression in adenocarcinoma and adenoma of the ampulla of Vater. Kim SJ; Lee HW; Kim DC; Rha SH; Hong SH; Jeong JS Pathol Int; 2008 Apr; 58(4):233-8. PubMed ID: 18324916 [TBL] [Abstract][Full Text] [Related]
16. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
17. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype. Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496 [TBL] [Abstract][Full Text] [Related]
18. [Expression of glucose transporter-1 in endometrial hyperplasia and well-differentiated endometrioid adenocarcinoma]. Liu AJ; Hou N; Chen LZ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):398-400. PubMed ID: 12940086 [TBL] [Abstract][Full Text] [Related]
19. Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Carter JH; Douglass LE; Deddens JA; Colligan BM; Bhatt TR; Pemberton JO; Konicek S; Hom J; Marshall M; Graff JR Clin Cancer Res; 2004 May; 10(10):3448-56. PubMed ID: 15161701 [TBL] [Abstract][Full Text] [Related]
20. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression. Elder DJ; Baker JA; Banu NA; Moorghen M; Paraskeva C J Pathol; 2002 Dec; 198(4):428-34. PubMed ID: 12434411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]